Concepedia

Jennifer Lattanze

JL

Statistics

Publications

10

Citations

911

H-Index

10

Active since

2004

Affiliations

Johnson & Johnson (United States)(Current)

Jennifer Lattanze is an author at Johnson & Johnson (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2004–2006

10

Publications

10

Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in Cells

Bruce Grasberger, Tianbao Lu, Carsten J. Schubert et al. · Journal of Medicinal Chemistry · 2005 · 427 citations · Full text

, , +14

1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2–p53 interaction: discovery and SAR

Daniel J. Parks, Louis V. LaFrance, Raul R. Calvo et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 167 citations

, , +11

Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein–protein interaction through structure-based drug design

Daniel J. Parks, Louis V. LaFrance, Raul R. Calvo et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 76 citations · Full text

, , +14

Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity

Kristi Leonard, Juan Marugán, Pierre Raboisson et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 60 citations · Full text

, , +4

Structure-based design, synthesis, and biological evaluation of novel 1,4-diazepines as HDM2 antagonists

Pierre Raboisson, Juan Marugán, Carsten J. Schubert et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 50 citations · Full text

, , +14

1–5 of 10